Policy and Regulation
ACA Marketplace Premiums Could Rise 20% in 2026
Healthcare policy analysts are projecting potentially significant premium increases of up to 20% for Affordable Care Act (ACA) marketplace plans in 2026, driven by a
Healthcare policy analysts are projecting potentially significant premium increases of up to 20% for Affordable Care Act (ACA) marketplace plans in 2026, driven by a
The FDA has granted clearance to Nyxoah’s innovative Genio system, a breakthrough hypoglossal nerve stimulation device designed to treat obstructive sleep apnea. This regulatory approval
HeartFlow has made a spectacular public market debut, with shares soaring 47% following the company’s $317 million initial public offering on Nasdaq. The strong market
A striking disconnect has emerged in healthcare’s artificial intelligence adoption, with new survey data revealing that while 99% of healthcare organizations are actively using generative
The digital health sector is experiencing a notable resurgence, with U.S. startups raising $6.4 billion in the first half of 2025, marking a modest but
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has unveiled an innovative Early Access program that will allow certain high-priority medical devices to enter
The Ruling’s Ripple Effect for SDK-Based Data Harvesting in Digital Health A landmark court ruling finding Meta liable for improperly collecting sensitive reproductive health data
Implications for Future Pandemic Readiness and Platform Vaccine Funding The Department of Health and Human Services’ decision to terminate multiple pandemic-era mRNA vaccine development programs
How Upcoming Tariffs Could Reshape Drug Pricing, Global Manufacturing, and Supply Chains President Trump’s latest threat to impose tariffs reaching 250% on pharmaceutical imports represents
Key Takeaways: Neurodegenerative diseases like Alzheimer’s, Parkinson’s, and ALS remain critical unmet needs in medicine. Biotech innovations, from gene therapies to biomarkers, are paving the